UA7208A1 - Спосіб одержання пентагідрату (6r,7r)-7-[(z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксііміно)-ацетамідо]-3-(1-пирідинійметил)-цеф-3-ем-4-карбоксилату - Google Patents

Спосіб одержання пентагідрату (6r,7r)-7-[(z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксііміно)-ацетамідо]-3-(1-пирідинійметил)-цеф-3-ем-4-карбоксилату

Info

Publication number
UA7208A1
UA7208A1 UA2987392A UA2987392A UA7208A1 UA 7208 A1 UA7208 A1 UA 7208A1 UA 2987392 A UA2987392 A UA 2987392A UA 2987392 A UA2987392 A UA 2987392A UA 7208 A1 UA7208 A1 UA 7208A1
Authority
UA
Ukraine
Prior art keywords
pyridiniummethyl
ceph
aminothiazol
oxyimino
acetamido
Prior art date
Application number
UA2987392A
Other languages
English (en)
Russian (ru)
Inventor
Купер Броуді Аластайр
Обрей Ветерілл Льюіс
Original Assignee
"Глексо Груп Лімітед"
"Глексо Груп Лимитед"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Глексо Груп Лімітед", "Глексо Груп Лимитед" filed Critical "Глексо Груп Лімітед"
Publication of UA7208A1 publication Critical patent/UA7208A1/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Предметом винаходу є спосіб одержання пентагідрату (6R, 7R)-7-[(Z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксиіміно)-ацетамідо]- 3-(1-піридинійметил)-цеф-3-ем-4-карбоксилату. рН розчину кислої або основної солі (6R,7R)-7-[(Z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксипроп-2-оксиіміно)-ацетамідо] 3-(1-піридинійметил)-цеф-3-ем-4-карбоксилату у водному середовищі доводиться до 2,7- 4,8 і цільовий продукт кристалізується.
UA2987392A 1979-10-02 1980-10-01 Спосіб одержання пентагідрату (6r,7r)-7-[(z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксііміно)-ацетамідо]-3-(1-пирідинійметил)-цеф-3-ем-4-карбоксилату UA7208A1 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02

Publications (1)

Publication Number Publication Date
UA7208A1 true UA7208A1 (uk) 1995-06-30

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2987392A UA7208A1 (uk) 1979-10-02 1980-10-01 Спосіб одержання пентагідрату (6r,7r)-7-[(z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксііміно)-ацетамідо]-3-(1-пирідинійметил)-цеф-3-ем-4-карбоксилату

Country Status (36)

Country Link
US (1) US4329453A (uk)
JP (1) JPS5657791A (uk)
KR (1) KR840001776B1 (uk)
AT (1) AT368161B (uk)
AU (1) AU539519B2 (uk)
BE (1) BE885489A (uk)
BG (1) BG33586A3 (uk)
CA (1) CA1142919A (uk)
CH (1) CH645118A5 (uk)
CS (1) CS214721B2 (uk)
CY (1) CY1338A (uk)
DD (1) DD153376A5 (uk)
DE (1) DE3037102C2 (uk)
DK (1) DK155525C (uk)
EC (1) ECSP941099A (uk)
ES (1) ES8106908A1 (uk)
FI (1) FI71157C (uk)
FR (1) FR2466467A1 (uk)
GB (1) GB2063871B (uk)
GR (1) GR69123B (uk)
HK (1) HK78686A (uk)
HU (1) HU184835B (uk)
IT (1) IT1144006B (uk)
KE (1) KE3641A (uk)
MX (1) MX6545E (uk)
MY (1) MY8500315A (uk)
NL (1) NL190329C (uk)
NO (1) NO156246C (uk)
PL (1) PL126606B1 (uk)
PT (1) PT71860B (uk)
RO (1) RO82721B (uk)
SE (1) SE449614B (uk)
SU (1) SU942599A3 (uk)
UA (1) UA7208A1 (uk)
YU (1) YU42357B (uk)
ZA (1) ZA806081B (uk)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
EP0169700B1 (en) * 1984-07-23 1990-05-16 Eli Lilly And Company Improved pharmaceutical formulations for ceftazidime
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
CA1239389A (en) * 1984-11-08 1988-07-19 Melvin G. Pleiss, Jr. Crystallization process
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
DE3871542T2 (de) * 1987-02-02 1992-12-24 Lilly Co Eli Verfahren zur herstellung von ceftazidime-pentahydrat.
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
RO82721B (ro) 1984-10-30
KR840001776B1 (ko) 1984-10-19
AU6288280A (en) 1981-04-09
PL126606B1 (en) 1983-08-31
GB2063871A (en) 1981-06-10
ZA806081B (en) 1982-05-26
DE3037102C2 (de) 1986-04-10
PL227019A1 (uk) 1981-06-05
KR830004317A (ko) 1983-07-09
FI71157C (fi) 1986-11-24
PT71860A (en) 1980-11-01
FI71157B (fi) 1986-08-14
SE449614B (sv) 1987-05-11
SU942599A3 (ru) 1982-07-07
BE885489A (fr) 1981-04-01
FI803126L (fi) 1981-04-03
ATA490080A (de) 1982-01-15
GR69123B (uk) 1982-05-03
IT1144006B (it) 1986-10-29
HU184835B (en) 1984-10-29
AT368161B (de) 1982-09-27
MX6545E (es) 1985-07-10
DK155525C (da) 1989-09-04
CY1338A (en) 1987-01-16
CH645118A5 (de) 1984-09-14
NL190329B (nl) 1993-08-16
BG33586A3 (en) 1983-03-15
IT8049783A0 (it) 1980-10-01
NL8005443A (nl) 1981-04-06
YU249780A (en) 1983-02-28
ES495534A0 (es) 1981-09-01
ECSP941099A (es) 1995-01-16
CA1142919A (en) 1983-03-15
HK78686A (en) 1986-10-24
PT71860B (en) 1982-04-02
DE3037102A1 (de) 1981-04-23
FR2466467B1 (uk) 1984-02-10
YU42357B (en) 1988-08-31
SE8006861L (sv) 1981-04-03
DK414780A (da) 1981-04-03
JPS5657791A (en) 1981-05-20
RO82721A (ro) 1984-09-29
CS214721B2 (en) 1982-05-28
NO156246C (no) 1987-08-19
NL190329C (nl) 1994-01-17
NO802913L (no) 1981-04-03
AU539519B2 (en) 1984-10-04
JPH0128036B2 (uk) 1989-05-31
DD153376A5 (de) 1982-01-06
ES8106908A1 (es) 1981-09-01
NO156246B (no) 1987-05-11
MY8500315A (en) 1985-12-31
US4329453A (en) 1982-05-11
FR2466467A1 (fr) 1981-04-10
DK155525B (da) 1989-04-17
GB2063871B (en) 1983-06-02
KE3641A (en) 1986-07-11

Similar Documents

Publication Publication Date Title
UA7208A1 (uk) Спосіб одержання пентагідрату (6r,7r)-7-[(z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксііміно)-ацетамідо]-3-(1-пирідинійметил)-цеф-3-ем-4-карбоксилату
IL57400A (en) (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl-2(2-carboxyprop-2-oxyimino)acetamido)-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylic acid and its derivatives,process for their preparation and pharmaceutical compositions comprising them
GB1319390A (en) Process for sterilising contact lenses
AU533708B2 (en) 7-(2-alkoxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl) acetamido) cephalosporanic acid derivatives
JPS53103493A (en) Cephalosporin derivatives and process for their preparation
MA20250A1 (fr) Procede de preparation de derives de cephalosporine.
IL58717A (en) Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(2-alkyl-pyrazolium-1-ylmethyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
ES8307823A1 (es) Procedimiento para la preparacion de sales cristalinas, solubles en agua, del acido 7-b-(2-(2-aminotiazol-4-il)-2-sin-metoxiimino-acetamido)-3-(5-carboximetil-4-metil-1,3-tiazol-2-il-tiometil)-cef-3-em-4-carboxilico.
KR870001216A (ko) 3-프로페닐 세팔로스포린 용매화물
AU571506B2 (en) Cristalline ceftazidime
TW266212B (uk)
IE811811L (en) Cephalosporins
ES8702918A1 (es) Un procedimiento para la preparacion de dihidrobromuro de acido (6r,7r)-7-((z)-2-(2-tritilaminotiazol-4-il)-2-(2-t-butiloxicarbonil-prop-2-oximino)acetamido)-3-(1piridiniometil)-3-cefem-4-carboxilico cristalino.
ZA817359B (en) Nikkomicin salts,a process for their preparation,pest-combating agents containing these salts and the preparation and use of these agents
CA1013344A (en) 7-(0-aminomethylphenyl-acetamido)-3-(tetrazolo(4,5-b)-pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
GB2012270A (en) Crystallisation process for sodium cefuroxime
DE3277870D1 (en) Cephalosporin compounds
JPS52122389A (en) Cephalosporin derivatives and their preparation
ES8501768A1 (es) Procedimiento para preparar (6r, 7r)-7-( (z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oximino)-acetamido)-3-(1-piridiniometil)-cef-3-em-carboxilato x 1, 5 moles de agua, cristalizado
CA959051A (en) Physical forms of the sodium salt of 7-(1h-tetrazol-1-ylacetamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl-thiomethyl)-3-cephem-4-carboxylic acid and new 7-acylated amino-3-thiolated methyl)ceph-3-em-4-carboxylic acid and their salts
DK536986D0 (da) Cephalosporinderivater, deres fremstilling og anvendelse
EP0109818A3 (en) Process for the preparation of penicillin and cephalosporin sulfones
ES8302007A1 (es) Procedimiento para la obtencion de la sal disodica del acido 7-(2-(2-amino-4-tiazolil)-2-metoxiimino-acetamido)-3-((2,5-dihidro-6-hidroxi-2-metil-5-oxo-as-triazin-3-il)tio)metil)-8-oxo-5-tia-1-azabiciclo (4.2.0)oct-2-ene-2-carboxilico
ES504448A0 (es) Procedimiento para preparar derivados de cefalosporina.
ES409592A1 (es) Un metodo para la preparacion de sales y esteres de acido 3-carbamoiloximetil-7-metoxi-7-(2(2-tienil) acetamido) dece- falosporanico.